This is the honest guide to what is actually going on. You will see what the hormone connection looks like in plain English. You will see why hormone replacement therapy is not the fix you might be hoping for. And you will see the drug-free moves that work when Restless Legs and menopause are happening together.

A woman in her late 40s in a quiet bedroom with her partner asleep beside her, the overlap of perimenopause and Restless Legs that wakes the women and not the men in the household

Why your Restless Legs got worse around perimenopause

You probably already know the pattern. Sleep was patchy for years, then it became unliveable. The hot flushes, the night sweats, the bedroom-temperature wars with your partner, and somewhere underneath all of it, the legs that refuse to settle. The order varies. The combination is depressingly common.

A 2008 paper by Wesström and colleagues in the journal Climacteric surveyed 5,000 Swedish women aged 18 to 64. Around 15.7 per cent of respondents met the criteria for Restless Legs Syndrome. The prevalence was meaningfully higher among women experiencing vasomotor symptoms (the hot-flush and night-sweat group) during the menopause transition. Other reviews put the worsening figure higher: up to 69 per cent of women with existing Restless Legs report their symptoms get worse around menopause. And if you had Restless Legs during pregnancy, you are roughly nine times more likely to develop it again post-menopause than women who did not.

If your gut has been telling you the timing is not a coincidence, the literature agrees with you.

What the research says about menopause and Restless Legs Syndrome

Three findings sit at the centre of the menopause-Restless Legs picture.

First, prevalence climbs. Restless Legs Syndrome is already more common in women than in men, roughly two to one across most populations. The gap widens further around the menopause transition. Women in their 40s and 50s are over-represented in every Restless Legs database.

Second, severity climbs. Women who had mild, intermittent Restless Legs in their 30s often report it becoming nightly and disruptive once perimenopause begins. The symptoms that used to show up before a long-haul flight or after wine now show up most evenings.

Third, the prior pregnancy connection is strong. Roughly 60 per cent of women who had Restless Legs during pregnancy go on to develop it post-menopause. The matching figure for women without pregnancy Restless Legs is only around 7 per cent. The two hormonal windows appear to share the same underlying vulnerability.

The hormone-dopamine connection in plain English

Restless Legs Syndrome is, at its core, a dopamine and iron story. Dopamine is the neurotransmitter the brain uses to manage movement signalling, and iron is one of the raw materials the brain needs to make dopamine in the first place. Both are involved in the urge-to-move pattern that defines Restless Legs.

Reproductive hormones, particularly oestrogen, interact with the dopamine system. The current best-evidence picture is that fluctuating oestrogen, the dramatic up-and-down of perimenopause rather than the steady low of post-menopause, interferes with dopamine function in a way that lets Restless Legs symptoms break through.

Iron is the other piece. The menopause transition is a window where ferritin (the body’s stored iron) often shifts. For some women, ferritin drops. For others, it sits in a grey zone that the standard blood test calls “normal” but the brain treats as too low for comfortable dopamine production. The 2024 American Academy of Sleep Medicine (AASM) clinical practice guideline now strongly recommends intravenous iron correction for adults whose serum ferritin sits below 100 micrograms per litre. That cutoff is well above the level most GPs flag as low.

Both pieces, hormones and iron, push on the same dopamine system. Around perimenopause, both can be moving at once. That is why so many women describe the legs getting much louder around the same time everything else got louder too.

Why hormone replacement therapy is not the Restless Legs fix you might hope for

This is the part of the conversation that surprises most women. If hormone shifts are doing this, surely topping up the hormones fixes it? The evidence does not bear that out.

Multiple studies have looked at hormone replacement therapy (HRT) in women with Restless Legs Syndrome. The result is consistent and slightly anticlimactic: HRT does not reliably reduce Restless Legs symptoms. It may help your hot flushes, your sleep quality through other routes, and your overall energy, all of which can indirectly take some weight off the legs. But the legs themselves do not respond predictably to oestrogen replacement. Some women on HRT see no Restless Legs change. A few report it gets worse.

The current best explanation: the disruption is in the change of hormones, not the absolute level. By the time HRT is started, the brain has already adapted to the new dopamine signalling pattern. Topping up the hormones does not reverse the adaptation.

If your menopause specialist is recommending HRT for vasomotor symptoms, sleep architecture, or bone density, the case for HRT can still be strong. Just do not expect it to be the Restless Legs answer. Plan separately for the legs.

What actually helps when Restless Legs and menopause are happening together

Here is the ordered plan most women in this window find useful. Same order as the broader drug-free Restless Legs plan, with one menopause-specific addition.

  1. Ask your GP for a serum ferritin test. The menopause transition shifts ferritin for many women, and the 2024 AASM guideline backs intravenous iron correction for adults under 100 micrograms per litre. Get the number.
  2. Cool the bedroom. This serves both the vasomotor symptoms and the Restless Legs. 18 to 20 degrees is the target. Fan, lighter sheets, lighter pyjamas.
  3. Audit caffeine and alcohol. Both worsen Restless Legs at night, and both worsen menopausal sleep through separate mechanisms. The cut is two-for-one.
  4. Add targeted overnight compression. Of all the non-drug options for Restless Legs Syndrome, this is the one with the strongest published trial data (Kuhn et al. 2016 showed a 90 per cent improvement on Clinical Global Impression versus 63 per cent for ropinirole). It does not interact with HRT, it does not interfere with menopause medications, and it is the part of the plan that does not require a doctor visit.
  5. Twenty-minute walk after dinner, five nights a week. Movement helps both sets of symptoms. (The full 11-method list for stopping Restless Legs at night covers the rest of the lifestyle layer.)
  6. Discuss the legs and the menopause separately with your specialist. They are connected biologically but they need separate treatment plans. Lumping them together is what gets women prescribed Sifrol on top of HRT, which the 2024 AASM guideline now suggests against because of augmentation risk.

The plan is layered. Most women find that ferritin plus bedroom cooling plus compression takes the legs from disrupting sleep to background noise, which is the part of the menopause picture they can fix without another prescription.

A Stillr sleep-ritual bundle on a nightstand, the calm-bedside version of a working perimenopause and Restless Legs plan

What the research actually shows

Three pieces of evidence underpin the case above.

Wesström et al. (2008), Climacteric. Population survey of 5,000 Swedish women aged 18 to 64, with a 70 per cent response rate. Overall Restless Legs Syndrome prevalence: 15.7 per cent. Prevalence was significantly higher among women with vasomotor symptoms during the menopause transition. Notably, HRT use was not associated with reduced Restless Legs prevalence in this sample.

Kuhn et al. (2016), Journal of the American Osteopathic Association. Eight-week randomised comparison of targeted foot compression against ropinirole in 30 adults with moderate-to-severe primary Restless Legs Syndrome. Compression produced 90 per cent improvement on the Clinical Global Impression scale; ropinirole produced 63 per cent. Compression was 1.4 times more effective than the drug, with no augmentation risk.

AASM clinical practice guideline (2024). Strong recommendation for intravenous ferric carboxymaltose for adults with serum ferritin under 100 micrograms per litre. Conditional-against recommendations for the older dopamine agonists pramipexole and ropinirole. Strong recommendation for the alpha-2-delta ligand class (gabapentin enacarbil, gabapentin, pregabalin) when medication is needed.

What the literature does not yet support: HRT as a Restless Legs treatment, oestrogen creams as a Restless Legs treatment, or any of the herbal “hormone balancing” products that are heavily marketed to perimenopausal women. The case for treating the legs and the hormones as separate clinical problems is strong.

What Stillr is, and isn’t

Stillr is a drug-free overnight compression sleeve, worn on both legs, designed to replicate the targeted-pressure mechanism behind the strongest non-drug evidence for Restless Legs Syndrome. It is unisex, comes in two sizes (Regular for AU women’s 5 to 8, Large for AU women’s 8.5 to 11 and men’s 7 to 10), and is currently pre-launch in Australia. Founders’ price is AUD $149 for the first 500 pairs. Every pair comes with a 30-Night Sleep Trial, full refund if it does not improve your sleep. Reserve your pair at stillr.com.au.

Stillr is not a medication, not a cure, not a treatment for any disease, including menopause. It is a wellness product, built around what the research suggests the body responds to, designed for the women who want to address the legs without adding another prescription to an already-complicated chapter.

If “drug-free, on my own terms” lands, join the founders’ list at stillr.com.au.